YOKNEAM, Israel and HONG KONG, March 3, 2021 / PRNewswire / – Baring Private Equity Asia (BPEA) and Lumenis today announced that they have entered into a definitive agreement to sell Lumenis Surgical Business to Boston Scientific (NYSE: BSX) in a transaction valued at $ 1.07 billion, subject to closing adjustments. The surgical sector includes laser and fiber solutions for minimally invasive surgical procedures in urology and ENT.
Lumenis’ high growth aesthetics and vision business will continue to operate under the ownership of BPEA. This strategic sale of the Surgery activity will allow Lumenis to accelerate its investments in both areas – in R&D, in…
News Highlights Business
- Headline: Baring Private Equity Asia Announces Agreement to Sell Lumenis Surgical Business to Boston Scientific for $ 1.07 Billion | News
- Check all news and articles from the Business news updates.